Viewing Study NCT00065533


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT00065533
Status: COMPLETED
Last Update Posted: 2007-06-22
First Post: 2003-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module